Del Mar Photonics
Dear Mr. Egorov,
You receive this newsletter information of our partner Carl Zeiss AG as you are
a subscriber to the World of Photonics News. If you do not wish to receive
newsletter information of our partners anymore, please unsubscribe here: http://pm.nmm.de/p/wop.php?c=43738789&p=5b970a01950026adfefdddbe8aa5efd0&type=uns
Carl Zeiss Research Award 2007:
Award to be presented at the LASER 2007 World of Photonics for the first time
The Carl Zeiss Research Award, one of the world's most prestigious prizes in
the field of optics, will be presented on 20 June 2007. The ceremony will take
place for the first time at the LASER 2007 World of Photonics exhibition in
Munich, Germany (18 - 21 June 2007).
Dr. Augustin Siegel, Senior Vice President, Corporate Research and Technology,
emphasizes: "The international public of the Laser 2007 World of Photonics is
precisely the right environment for presenting the Carl Zeiss Research Award.
The World of Photonics congress, which takes place at the same time as the
exhibition, offers an excellent forum comprising experts from the fields of
optics and photonics."
This year, Carl Zeiss is honoring primarily international scientists in
recognition of their outstanding achievements in basic research and applied
optics. The sum of 25,000 euros has been allocated to the Carl Zeiss Research
At the LASER World of Photonics in Munich, Carl Zeiss is represented by three
of its business areas. The Camera Lens division, the Spectral Sensors business
unit of Carl Zeiss MicroImaging GmbH and the Jena Service Center will all be
participating with their products.
Visit us at our Booth 403 in Hall B.2
Carl Zeiss Group on Course to Further Growth:
Revenues climbed 12 percent - earnings strongly increased - 250 new jobs
created - second half of fiscal year starts with full order books
Carl Zeiss is continuing its course to further growth: the international group
of companies posted a very good interim result for the first six months of FY
2006/07 (October 1, 2006 - March 31, 2007): revenues rose 12 percent over the
same period last year to EUR 1,303 million (first half year 2005/06: EUR 1,163
million). Without currency fluctuations, Carl Zeiss would have even achieved
revenue growth of 14 percent. Carl Zeiss posted an increase in revenues in all
major economic regions of the world during the first six months. Business in
Europe, in particular, developed very positively.
EBIT (Earnings before Interest and Taxes) rose 24 percent to EUR 189 million
(153 million during the first half of 2005/06). Without currency fluctuations,
EBIT would have even risen 29 percent. At the press conference held on May 24,
2007, in Stuttgart, Dr. Dieter Kurz, President and CEO of Carl Zeiss AG,
explained that "Carl Zeiss continually grew during the first six months and has
once again exceeded the success of the previous year. With an EBIT margin of
almost 15 percent, the company ranks among the top corporations in
Research and development strengthened:
Research and development spending reached a peak value during the first six
months: Carl Zeiss invested a total of EUR 137 million - or 11 percent of
revenues - to strengthen its innovative power (same period in 2005/06: 110
million). "Innovation is our business. We generate almost 60 percent of our
revenues with products that are not older than five years. We invest heavily in
research and development to further expand our technology leadership,"
emphasizes Dr. Dieter Kurz.
Further Increase in Equity Ratio:
The equity ratio reached 27 percent. This represents an increase of 5
percentage points in the first six months (year end 2005/06: 22 percent) and is
nearing the mid-term target of 30 percent.
With EUR 255 million, or 20 percent of revenues, pretax cashflow has reached a
very high level (first six months of 2005/06: 191 million; 16 percent of
revenues). Net liquidity continued to improve with the positive development of
cashflow: it rose 115 percent during the first 6 months of the fiscal year (FY
2005/06 year end: EUR 275 million) and reached EUR 590 million.
"As a result of the good operational cashflow, the Carl Zeiss Group has a very
solid financial basis - despite the many acquisitions in recent years and the
expenses for the contractual trust agreement to which we transferred EUR 242
million exclusively for the fulfillment of pension claims. We are in a very
good position to systematically implement our growth strategy," said CFO Dr.
Clear improvement in corporate value:
With an EVA?(Economic Value Added) of EUR 62 million, the Carl Zeiss Group
once again clearly improved its corporate value during the first half year (39
million during the first half of 2005/06). This corresponds to an increase of
More than 250 new jobs:
On March 31, 2007, Carl Zeiss employed 11,586 people around the world. This is
405 employees - approximately four percent - more than the same period last
year (11,181). During the first six months of the current fiscal year, the Carl
Zeiss Group created more than 250 new jobs for skilled workers, more than half
of them in Germany. Changes to the scope of consolidation also contributed to
Carl Zeiss enhanced its portfolio during the current fiscal year through
strategic acquisitions: at the beginning of March, the Microscopy Group (Carl
Zeiss MicroImaging GmbH) acquired the instrument business of Clarient, Inc. in
Aliso Viejo, California. Clarient is a leading provider of technologies and
solutions for diagnostics in pathology and oncology, as well as for the
pharmaceutical industry. This acquisition provides Carl Zeiss MicroImaging with
new growth opportunities in the promising market of clinical cancer diagnostics
Carl Zeiss Optronics GmbH signed a contract at the middle of March for the
acquisition of the majority of Denel Optronics. The South African company
offers innovative products for civilian security and defense purposes, and
ideally supplements the product portfolio of Carl Zeiss Optronics GmbH. With
the acquisition of a 70 percent share in Denel Optronics, Carl Zeiss Optronics
is consistently pursuing its growth strategy. The approval of this transaction
by the antitrust authorities is expected in June.
Carl Zeiss is a leading international group of companies operating worldwide in
the optical and opto-electronic industry. Carl Zeiss AG is headquartered in
Oberkochen, Germany. The business groups, which each operate with sole
responsibility, are generally ranked first or second in the strategic markets
of medical and research solutions, industrial solutions und lifestyle products.
They offer products and services for biomedical research and medical technology,
as well as system solutions for the semiconductor, automotive and mechanical
engineering industries. Planetariums and high-quality consumer goods such as
camera lenses and binoculars carry the ZEISS name to millions of users around
the world. In fiscal year 2005/06 (ended 30 September), the Carl Zeiss Group,
which is wholly owned by the Carl Zeiss Foundation, generated sales totaling
EUR 2,433 million. The Carl Zeiss Group has approximately 11,250 employees,
including about 3,400 outside Germany. It is directly represented in more than
30 countries and operates production facilities in Europe, America and Asia.
The eyeglass business operates as Carl Zeiss Vision International GmbH and is
the number two eyeglass provider in the world. This company is owned 50:50 by
Carl Zeiss AG and a private equity company. Further information is available at